Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will present at the 17th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2015, at 2:00 p.m. Eastern Time. The conference is being held at the Waldorf Astoria Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
